当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
PALFORZIA, Peanut (Arachis hypogaea) Allergen Powder
申请企业
Aimmune Therapeutics, Inc.
药品名称
PALFORZIA, Peanut (Arachis hypogaea) Allergen Powder
承诺描述
Deferred pediatric study under PREA for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut in pediatric patients ages 1 through less than 4 years.